Nothing Special   »   [go: up one dir, main page]

UA97957C2 - 2-{5-fluoro-2-methyl-3-[2-(phenylsulfonyl)benzyl]-1h-indol-1-yl}acetic acid and derivatives thereof, use thereof for the treatment of diseases mediated by pgd2 action at the crth2 receptor - Google Patents

2-{5-fluoro-2-methyl-3-[2-(phenylsulfonyl)benzyl]-1h-indol-1-yl}acetic acid and derivatives thereof, use thereof for the treatment of diseases mediated by pgd2 action at the crth2 receptor

Info

Publication number
UA97957C2
UA97957C2 UAA200900835A UAA200900835A UA97957C2 UA 97957 C2 UA97957 C2 UA 97957C2 UA A200900835 A UAA200900835 A UA A200900835A UA A200900835 A UAA200900835 A UA A200900835A UA 97957 C2 UA97957 C2 UA 97957C2
Authority
UA
Ukraine
Prior art keywords
treatment
pgd2
phenylsulfonyl
indol
fluoro
Prior art date
Application number
UAA200900835A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Ричард Эдвард Армер
Грахам Михаэль Вайн
Original Assignee
Оксаджен Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Оксаджен Лимитед filed Critical Оксаджен Лимитед
Priority claimed from PCT/GB2007/002761 external-priority patent/WO2008012511A1/en
Publication of UA97957C2 publication Critical patent/UA97957C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compounds of general formula (I) wherein R is phenyl optionally substituted with one or more halo substituents; and their pharmaceutically acceptable salts, hydrates, solvates, complexes or prodrugs are useful in orally administrable compositions for the treatment of allergic diseases such as asthma, allergic rhinitis and atopic dermatitis., (I)
UAA200900835A 2006-07-22 2007-07-20 2-{5-fluoro-2-methyl-3-[2-(phenylsulfonyl)benzyl]-1h-indol-1-yl}acetic acid and derivatives thereof, use thereof for the treatment of diseases mediated by pgd2 action at the crth2 receptor UA97957C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0614608A GB0614608D0 (en) 2006-07-22 2006-07-22 Compounds having CRTH2 antagonist activity
PCT/GB2007/002761 WO2008012511A1 (en) 2006-07-22 2007-07-20 Compounds having crth2 antagonist activity

Publications (1)

Publication Number Publication Date
UA97957C2 true UA97957C2 (en) 2012-04-10

Family

ID=36998568

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200900835A UA97957C2 (en) 2006-07-22 2007-07-20 2-{5-fluoro-2-methyl-3-[2-(phenylsulfonyl)benzyl]-1h-indol-1-yl}acetic acid and derivatives thereof, use thereof for the treatment of diseases mediated by pgd2 action at the crth2 receptor

Country Status (4)

Country Link
CN (1) CN101506159B (en)
GB (1) GB0614608D0 (en)
UA (1) UA97957C2 (en)
ZA (1) ZA200900393B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111458507B (en) * 2020-04-14 2023-09-12 中国人民解放军海军军医大学第三附属医院 Marker for evaluating sensitivity of intrahepatic bile duct cancer gemcitabine chemotherapy and application thereof
CN113684238A (en) * 2021-08-09 2021-11-23 广州医科大学附属第一医院（广州呼吸中心） Use of CXC chemokine receptor 3 as cough drug target
CN114478350B (en) * 2022-01-25 2023-08-11 苏州大学 Preparation method of C3-alkylated indole
CN114609272B (en) * 2022-02-22 2023-08-11 植恩生物技术股份有限公司 Method for detecting mesilate impurity JH-ZZD

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5641800A (en) * 1994-07-21 1997-06-24 Eli Lilly And Company 1H-indole-1-functional sPLA2 inhibitors
EP2423190A1 (en) * 2002-05-16 2012-02-29 Shionogi&Co., Ltd. Compounds Exhibiting PGD 2 Receptor Antagonism

Also Published As

Publication number Publication date
ZA200900393B (en) 2010-03-31
CN101506159A (en) 2009-08-12
GB0614608D0 (en) 2006-08-30
CN101506159B (en) 2012-08-22

Similar Documents

Publication Publication Date Title
NZ561747A (en) (Pyrrol-2-ylmethyl)-indol-1-yl-acetic acid derivatives with PGD2 antagonist activity
NO20090216L (en) Compounds with CRTH2 antagonist activity
GB0510584D0 (en) Organic compounds
NO20061456L (en) Use of CRTH2 antagonist compounds in therapy
EA023861B3 (en) Pyrrolidine carboxylic acid derivatives as agonists of g-protein coupled receptor 43 (gpr43), pharmaceutical composition and methods for use thereof in treating metabolic disorders
TW200833675A (en) Nicotinamide derivatives
NZ581698A (en) Polycyclic indazole derivatives and their use as erk inhibitors for the treatment of cancer
MX2008009413A (en) Heterocycles as nicotinic acid receptor agonists for the treatment of dyyslipidemia.
TW200716648A (en) Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
MX2009009492A (en) Bicyclic organic compounds suitable for the treatment of inflammatory or allergic conditions.
TW200640869A (en) PGD2 receptor antagonists for the treatment of inflammatory diseases
WO2008130879A3 (en) Tetrahydroindole and tetrahydroindazole derivatives
MX2009013885A (en) Fused quinoline derivatives useful as gaba modulators.
EA200700103A1 (en) NEW 2-SUBSTITUTED D-HOMO-ESTRA-1,3,5 (10) -TRIENES AS INHIBITORS OF 17β-HYDROXYSTEROID DEHYDROGENASE TYPE 1
UA97957C2 (en) 2-{5-fluoro-2-methyl-3-[2-(phenylsulfonyl)benzyl]-1h-indol-1-yl}acetic acid and derivatives thereof, use thereof for the treatment of diseases mediated by pgd2 action at the crth2 receptor
WO2011151436A3 (en) Azepin-derivatives as derivatives as g- protein coupled receptor (gpr43) agonists
CY1112638T1 (en) USE OF INDOLIUM PRODUCERS AS NURR-1 ACTIVATORS FOR RARKINSON'S DISEASE TREATMENT
TW200621241A (en) Process for the preparation of isothiazole derivatives
ATE495159T1 (en) DIAMINOCYCLOHEXANE AND DIAMINOCYCLOPENETE DERIVATIVES
TN2009000056A1 (en) Polymorphic crystal form of a indian -2-ylamino-hydroxyethyl -quinolinone maleate derivative as beta - adrenoceptro agonist
ATE475642T1 (en) PHENOXYACETIC ACID DERIVATIVES AS PPAR AGONISTS
MY145122A (en) Phenylacetic acid derivatives as cox-2 inhibitors
DE602006016244D1 (en) DIAZASPIRO Ä4,4Ü NONANDERIVATES AS NEUROKININ (NK1) ANTAGONISTS
UA104584C2 (en) Compounds having crth2 antagonist activity
WO2009089284A3 (en) Substituted 2-aminotetralin derivatives as selective alpha 2b agonist